{"id":12759,"date":"2025-04-07T00:50:22","date_gmt":"2025-04-07T00:50:22","guid":{"rendered":"https:\/\/tribunavm.com.ar\/?p=12759"},"modified":"2025-04-05T22:08:46","modified_gmt":"2025-04-05T22:08:46","slug":"nuevo-organismo-sanitario-estatal","status":"publish","type":"post","link":"https:\/\/tribunavm.com.ar\/index.php\/2025\/04\/07\/nuevo-organismo-sanitario-estatal\/","title":{"rendered":"Nuevo organismo sanitario divide a las farmac\u00e9uticas"},"content":{"rendered":"
\n
\n

El Gobierno anunci\u00f3 la creaci\u00f3n por decreto de la Agencia Nacional de Evaluaci\u00f3n de Financiamiento de Tecnolog\u00edas Sanitarias (Anefits).<\/span><\/p>\n

E<\/span>l nuevo organismo evaluar\u00e1 el valor y la contribuci\u00f3n de los medicamentos antes de que la Anmat lo autorice, por lo que tendr\u00eda la potestad de decidir el ingreso al pa\u00eds de medicamentos, dispositivos, test diagn\u00f3stico y otros insumos de salud.
\n<\/span><\/p>\n

Manuel Adorni, vocero presidencial, argument\u00f3 a la prensa que el organismo evitar\u00e1 \u201cque los pacientes sean sometidos a tratamientos con efectos adversos o que no les generen beneficios para su salud, lo que ven\u00eda ocurriendo en la Argentina\u201d.<\/span><\/p>\n

A la espera de la publicaci\u00f3n del decreto que oficialice la creaci\u00f3n del Anefits y precise su vinculaci\u00f3n con la Anmat, organismo que autoriza la comercializaci\u00f3n en el mercado local, <\/span>el anuncio gener\u00f3 el posicionamiento de los empresarios del sector farmac\u00e9utico<\/b>.<\/span><\/p>\n

La salud y el lucro, juntos de la mano<\/span><\/a><\/span><\/p><\/blockquote>\n

La c\u00e1mara nacional del sector, la C\u00e1mara Industrial de Laboratorios Farmac\u00e9uticos Argentinos (CILFA) celebr\u00f3 la medida<\/b>. \u201cUna decisi\u00f3n acertada de pol\u00edtica sanitaria, que coloca a la Argentina entre un selecto grupo de naciones que cuenta con este tipo de agencia que ejerce la rector\u00eda en la aprobaci\u00f3n de medicamentos de innovaci\u00f3n\u201d, expres\u00f3 en un comunicado.<\/span><\/p>\n

Por su parte, la<\/span> C\u00e1mara Argentina de Especialidades Medicinales (CAEME), <\/span>que representa a empresas biotecnol\u00f3gicas de la Argentina, Estados Unidos, Europa, Jap\u00f3n y Australia, plante\u00f3 su preocupaci\u00f3n <\/b>por que la medida \u201cpodr\u00eda impedir o retrasar por a\u00f1os la disponibilidad y acceso de los pacientes en Argentina a los \u00faltimos tratamientos en salud ya disponibles en el mundo\u201d, ante los criterios de evaluaci\u00f3n de la Anefits.<\/span><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

El Gobierno anunci\u00f3 la creaci\u00f3n por decreto de la Agencia Nacional de Evaluaci\u00f3n de Financiamiento de Tecnolog\u00edas Sanitarias (Anefits).<\/p>\n","protected":false},"author":2,"featured_media":12760,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"jnews-multi-image_gallery":[],"jnews_single_post":{"format":"standard","override":[{"template":"5","parallax":"1","fullscreen":"1","layout":"right-sidebar","sidebar":"default-sidebar","second_sidebar":"default-sidebar","sticky_sidebar":"1","share_position":"hide","share_float_style":"share-monocrhome","show_featured":"1","show_post_meta":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"custom","post_date_format_custom":"d-m-Y","show_post_category":"1","post_reading_time_wpm":"300","post_calculate_word_method":"count_blank","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","number_popup_post":"1","show_author_box":"0","show_post_related":"1"}],"image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post_position":"meta","trending_post_label":"Trending","sponsored_post_label":"Sponsored by","disable_ad":"0"},"jnews_primary_category":[],"jnews_social_meta":[],"jnews_override_counter":{"view_counter_number":"0","share_counter_number":"0","like_counter_number":"0","dislike_counter_number":"0"},"_joinchat":[],"footnotes":""},"categories":[279],"tags":[68],"class_list":["post-12759","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gobierno","tag-salud"],"_links":{"self":[{"href":"https:\/\/tribunavm.com.ar\/index.php\/wp-json\/wp\/v2\/posts\/12759"}],"collection":[{"href":"https:\/\/tribunavm.com.ar\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tribunavm.com.ar\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tribunavm.com.ar\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/tribunavm.com.ar\/index.php\/wp-json\/wp\/v2\/comments?post=12759"}],"version-history":[{"count":2,"href":"https:\/\/tribunavm.com.ar\/index.php\/wp-json\/wp\/v2\/posts\/12759\/revisions"}],"predecessor-version":[{"id":12764,"href":"https:\/\/tribunavm.com.ar\/index.php\/wp-json\/wp\/v2\/posts\/12759\/revisions\/12764"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tribunavm.com.ar\/index.php\/wp-json\/wp\/v2\/media\/12760"}],"wp:attachment":[{"href":"https:\/\/tribunavm.com.ar\/index.php\/wp-json\/wp\/v2\/media?parent=12759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tribunavm.com.ar\/index.php\/wp-json\/wp\/v2\/categories?post=12759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tribunavm.com.ar\/index.php\/wp-json\/wp\/v2\/tags?post=12759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}